|
|||||
|
|
Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice |
|
| Authors: | Kamlesh Khunti MD PhD Serge Jabbour MD Xavier Cos MD PhD Sunder Mudaliar MD Christian Mende MD Marc Bonaca MD Paola Fioretto MD PhD |
| Institution: | 1. Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK;2. Thomas Jefferson University, Philadelphia, Pennsylvania, USA;3. Sant Marti de Provençals Primary Care Centres, Barcelona, Spain
Institut Català de la Salut. IDIAP Jordi Gol. DAP_Cat Study Group CIBERDEM, Universitat Autonoma de Barcelona, Barcelona, Spain;4. Department of Medicine, University of California, San Diego School of Medicine, San Diego, California, USA Veterans Affairs Medical Center, San Diego, California, USA;5. Department of Medicine, University of California San Diego, La Jolla, California, USA;6. Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora CO;7. CPC Clinical Research, Aurora, Colorado, USA;8. Department of Medicine, University of Padua, Unite of Medical Clinic 3, Hospital of Padua, Padua, Italy |
| Abstract: | |
| Keywords: | guidelines sodium-glucose co-transporter-2 inhibitors type 2 diabetes uptake |